Capital Group’s $107 Million Investment in Intas Pharmaceuticals

The Hong Kong office of Debevoise & Plimpton has advised Capital Group in its acquisition of an equity stake in Intas Pharmaceuticals Limited (“Intas”), one of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here